These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1445490)

  • 21. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
    Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST; Mortensen A
    Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.
    Denton CP; Bunce TD; Dorado MB; Roberts Z; Wilson H; Howell K; Bruckdorfer KR; Black CM
    Rheumatology (Oxford); 1999 Apr; 38(4):309-15. PubMed ID: 10378706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
    Noguchi N; Gotoh N; Niki E
    Biochim Biophys Acta; 1994 Jul; 1213(2):176-82. PubMed ID: 8025128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
    El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
    Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients.
    Morena M; Cristol JP; Dantoine T; Carbonneau MA; Descomps B; Canaud B
    Nephrol Dial Transplant; 2000 Mar; 15(3):389-95. PubMed ID: 10692526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probucol in hypercholesterolemia. A double blind study.
    Riesen WF; Keller M; Mordasini R
    Atherosclerosis; 1980 Jun; 36(2):201-7. PubMed ID: 7406949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidation resistance of LDL in hypertriglyceridaemic patients treated with ciprofibrate.
    Nagyová A; Raslová K; Ginter E
    Physiol Res; 1998; 47(3):185-90. PubMed ID: 9803483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive correlation between probucol in low density lipoprotein and LDL-lowering.
    Shinomiya M; Shirai K; Saito Y; Yoshida S
    Eur J Clin Pharmacol; 1993; 45(4):343-6. PubMed ID: 8299667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
    Tomikawa M; Nakayasu T; Tawara K; Abiko Y
    Atherosclerosis; 1981 Oct; 40(2):101-13. PubMed ID: 6946776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Banana prevents plasma oxidative stress in healthy individuals.
    Yin X; Quan J; Kanazawa T
    Plant Foods Hum Nutr; 2008 Jun; 63(2):71-6. PubMed ID: 18264767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
    Jialal I; Grundy SM
    J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer.
    Bagdade JD; Kaufman D; Ritter MC; Subbaiah PV
    Atherosclerosis; 1990 Oct; 84(2-3):145-54. PubMed ID: 2282096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.
    Dachet C; Jacotot B; Buxtorf JC
    Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma lipid composition and LDL oxidation.
    Brizzi P; Tonolo G; Carusillo F; Malaguarnera M; Maioli M; Musumeci S
    Clin Chem Lab Med; 2003 Jan; 41(1):56-60. PubMed ID: 12636050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effect of gemfibrozil on the chemical composition and oxidative susceptibility of low density lipoprotein: a randomized, double-blind, placebo-controlled study.
    Yoshida H; Ishikawa T; Ayaori M; Shige H; Ito T; Suzukawa M; Nakamura H
    Atherosclerosis; 1998 Jul; 139(1):179-87. PubMed ID: 9699906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probucol protects lipoprotein (a) against oxidative modification.
    Naruszewicz M; Selinger E; Dufour R; Davignon J
    Metabolism; 1992 Nov; 41(11):1225-8. PubMed ID: 1435295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.
    Eto M; Sato T; Watanabe K; Iwashima Y; Makino I
    Atherosclerosis; 1990 Sep; 84(1):49-53. PubMed ID: 2248620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.